vimarsana.com
Home
Live Updates
FDA Accepts Resubmitted NDA for Arimoclomol for Niemann-Pick
FDA Accepts Resubmitted NDA for Arimoclomol for Niemann-Pick
FDA Accepts Resubmitted NDA for Arimoclomol for Niemann-Pick Disease Type C
The FDA has accepted the resubmitted New Drug Application (NDA) for arimoclomol for the treatment of Niemann-Pick disease type C.
Related Keywords
,
Drug Administration ,
European Union ,
New Drug Application ,
Complete Response Letter ,
Severity Scale ,